Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 Dec;41(12):889-91.

Increasing clinical pregnancy rates after IVF/ET. Can immunosuppression help?

G L Mottla  1 , D B Smotrich, P R Gindoff, R J Stillman
Affiliations
  • PMID: 8979201
Clinical Trial

Increasing clinical pregnancy rates after IVF/ET. Can immunosuppression help?

G L Mottla et al. J Reprod Med. 1996 Dec.

Abstract

Objective: To evaluate the safety and efficacy of immunosuppression as an adjunct to improving the success of in vitro fertilization/embryo transfer (IVF-ET).

Study design: A randomized, double-blind, placebo-controlled clinical trial.

Results: Seventy-five patients were randomized to receive either prednisone (39 patients, 51%) or placebo (36 patients, 49%). Patients in both groups had similar ages and numbers of preembryos transferred.

Conclusion: Both the implantation and clinical pregnancy rates were higher in the prednisone group (16% vs. 11% and 43.5% vs. 32.3%, respectively). However, these differences did not achieve statistical significance. Evaluation of the ongoing pregnancy rate revealed little difference between the prednisone-treated patients (30.7%) and those receiving placebo (28.0%). There were no side effects reported by patients in either group.

PubMed Disclaimer

Publication types